Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 242 | 2024 | 1604 | 29.500 |
Why?
|
Geriatric Assessment | 57 | 2021 | 1366 | 5.110 |
Why?
|
Health Services for the Aged | 14 | 2023 | 268 | 4.220 |
Why?
|
Hospitalization | 69 | 2023 | 10208 | 3.690 |
Why?
|
Dementia | 44 | 2023 | 2488 | 3.520 |
Why?
|
Activities of Daily Living | 43 | 2023 | 2410 | 3.370 |
Why?
|
Geriatrics | 15 | 2021 | 396 | 2.910 |
Why?
|
Postoperative Complications | 57 | 2023 | 15194 | 2.880 |
Why?
|
Confusion | 12 | 2021 | 271 | 2.300 |
Why?
|
Aged | 282 | 2024 | 162698 | 2.230 |
Why?
|
Neuropsychological Tests | 33 | 2021 | 6963 | 2.190 |
Why?
|
Cognition Disorders | 28 | 2019 | 4026 | 2.130 |
Why?
|
Accidental Falls | 13 | 2018 | 1055 | 1.960 |
Why?
|
Geriatric Nursing | 9 | 2021 | 39 | 1.900 |
Why?
|
Length of Stay | 26 | 2022 | 6295 | 1.750 |
Why?
|
Long-Term Care | 5 | 2020 | 606 | 1.720 |
Why?
|
Cognition | 29 | 2023 | 6686 | 1.630 |
Why?
|
Aged, 80 and over | 143 | 2022 | 57650 | 1.610 |
Why?
|
Nursing Homes | 12 | 2022 | 1029 | 1.550 |
Why?
|
Hospitals | 16 | 2023 | 3916 | 1.500 |
Why?
|
Inpatients | 13 | 2022 | 2478 | 1.360 |
Why?
|
Frail Elderly | 9 | 2021 | 690 | 1.340 |
Why?
|
Postoperative Care | 4 | 2018 | 1477 | 1.340 |
Why?
|
Antipsychotic Agents | 8 | 2023 | 3055 | 1.320 |
Why?
|
Iatrogenic Disease | 6 | 2020 | 544 | 1.320 |
Why?
|
Intensive Care Units | 19 | 2022 | 3672 | 1.300 |
Why?
|
Prospective Studies | 106 | 2023 | 53037 | 1.290 |
Why?
|
Humans | 360 | 2024 | 739398 | 1.220 |
Why?
|
Aging | 19 | 2023 | 8613 | 1.160 |
Why?
|
Internal Medicine | 2 | 2024 | 996 | 1.130 |
Why?
|
Alzheimer Disease | 23 | 2024 | 7975 | 1.120 |
Why?
|
Caregivers | 13 | 2021 | 2067 | 1.090 |
Why?
|
Psychological Tests | 5 | 2014 | 649 | 1.060 |
Why?
|
Walking | 4 | 2017 | 1177 | 1.020 |
Why?
|
Program Development | 7 | 2018 | 1313 | 1.010 |
Why?
|
Nursing Assessment | 5 | 2021 | 107 | 1.000 |
Why?
|
Male | 203 | 2023 | 349022 | 0.980 |
Why?
|
Female | 215 | 2024 | 378853 | 0.970 |
Why?
|
Abdomen | 3 | 2017 | 1104 | 0.960 |
Why?
|
Hospitals, Community | 4 | 2013 | 347 | 0.950 |
Why?
|
Program Evaluation | 11 | 2020 | 2484 | 0.930 |
Why?
|
Hospital Administration | 2 | 2020 | 354 | 0.910 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1058 | 0.860 |
Why?
|
Loneliness | 1 | 2023 | 181 | 0.790 |
Why?
|
Risk Factors | 68 | 2023 | 71974 | 0.780 |
Why?
|
Psychometrics | 18 | 2022 | 2995 | 0.750 |
Why?
|
Severity of Illness Index | 32 | 2021 | 15511 | 0.750 |
Why?
|
Interview, Psychological | 4 | 2016 | 812 | 0.750 |
Why?
|
Evidence-Based Practice | 3 | 2021 | 500 | 0.740 |
Why?
|
Homes for the Aged | 3 | 2020 | 260 | 0.740 |
Why?
|
Psychiatric Status Rating Scales | 19 | 2021 | 6028 | 0.720 |
Why?
|
Connecticut | 15 | 2009 | 363 | 0.710 |
Why?
|
Recovery of Function | 6 | 2020 | 2924 | 0.700 |
Why?
|
Research Design | 15 | 2020 | 5959 | 0.700 |
Why?
|
Institutionalization | 3 | 2015 | 104 | 0.680 |
Why?
|
Nutritional Support | 2 | 2018 | 168 | 0.670 |
Why?
|
Dexmedetomidine | 1 | 2023 | 315 | 0.670 |
Why?
|
Orthopedic Procedures | 6 | 2022 | 1286 | 0.670 |
Why?
|
Medication Reconciliation | 1 | 2020 | 151 | 0.660 |
Why?
|
Interviews as Topic | 11 | 2020 | 2533 | 0.660 |
Why?
|
Evidence-Based Medicine | 7 | 2023 | 3606 | 0.650 |
Why?
|
Acute Disease | 9 | 2020 | 7128 | 0.650 |
Why?
|
Medical Records | 4 | 2014 | 1413 | 0.650 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 287 | 0.640 |
Why?
|
Subacute Care | 3 | 2017 | 168 | 0.640 |
Why?
|
Biomedical Research | 10 | 2023 | 3301 | 0.630 |
Why?
|
Patient Care Planning | 4 | 2011 | 918 | 0.630 |
Why?
|
Electroencephalography | 9 | 2022 | 6133 | 0.630 |
Why?
|
Checklist | 2 | 2022 | 817 | 0.620 |
Why?
|
Incidence | 30 | 2023 | 20913 | 0.620 |
Why?
|
Mobility Limitation | 2 | 2020 | 403 | 0.620 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 927 | 0.610 |
Why?
|
Organizational Culture | 2 | 2020 | 510 | 0.610 |
Why?
|
Pharmacoepidemiology | 1 | 2020 | 322 | 0.600 |
Why?
|
Critical Care | 6 | 2022 | 2624 | 0.580 |
Why?
|
Cohort Studies | 45 | 2023 | 40389 | 0.580 |
Why?
|
Diagnostic Errors | 2 | 2020 | 1253 | 0.570 |
Why?
|
Quality of Health Care | 9 | 2016 | 4365 | 0.570 |
Why?
|
Cardiac Surgical Procedures | 6 | 2020 | 3517 | 0.570 |
Why?
|
Delivery of Health Care | 10 | 2023 | 5272 | 0.570 |
Why?
|
Social Justice | 1 | 2021 | 456 | 0.560 |
Why?
|
Patient Selection | 5 | 2020 | 4211 | 0.560 |
Why?
|
Reproducibility of Results | 36 | 2022 | 19811 | 0.550 |
Why?
|
Analgesics | 2 | 2020 | 1034 | 0.550 |
Why?
|
Patient Discharge | 10 | 2022 | 3286 | 0.540 |
Why?
|
Drug Therapy, Computer-Assisted | 2 | 2008 | 203 | 0.540 |
Why?
|
Patient Readmission | 10 | 2021 | 3106 | 0.530 |
Why?
|
Goals | 4 | 2004 | 702 | 0.530 |
Why?
|
Mortality | 5 | 2016 | 2851 | 0.530 |
Why?
|
DNA, Single-Stranded | 8 | 1992 | 351 | 0.530 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 5 | 2022 | 1951 | 0.510 |
Why?
|
Quality Improvement | 5 | 2020 | 3730 | 0.510 |
Why?
|
Adaptation, Psychological | 4 | 2019 | 2564 | 0.510 |
Why?
|
DNA, Bacterial | 11 | 2005 | 1467 | 0.510 |
Why?
|
Benzodiazepines | 3 | 2023 | 1099 | 0.500 |
Why?
|
Hypnotics and Sedatives | 4 | 2023 | 1158 | 0.490 |
Why?
|
Online Systems | 1 | 2015 | 184 | 0.480 |
Why?
|
Nursing Staff, Hospital | 4 | 2021 | 346 | 0.480 |
Why?
|
Cephalometry | 1 | 2016 | 381 | 0.480 |
Why?
|
Reminder Systems | 2 | 2008 | 370 | 0.480 |
Why?
|
RNA-Directed DNA Polymerase | 10 | 1994 | 248 | 0.480 |
Why?
|
Risk Adjustment | 3 | 2003 | 591 | 0.470 |
Why?
|
Night Care | 1 | 2013 | 28 | 0.470 |
Why?
|
Mass Screening | 11 | 2022 | 5265 | 0.460 |
Why?
|
Preoperative Care | 4 | 2020 | 2238 | 0.460 |
Why?
|
Medicine | 1 | 2022 | 930 | 0.460 |
Why?
|
Expert Testimony | 2 | 2019 | 355 | 0.460 |
Why?
|
Clinical Protocols | 7 | 2020 | 1453 | 0.450 |
Why?
|
Surgical Procedures, Operative | 4 | 2019 | 1867 | 0.450 |
Why?
|
Organizational Objectives | 2 | 2013 | 439 | 0.440 |
Why?
|
Telephone | 1 | 2016 | 617 | 0.440 |
Why?
|
RNA, Bacterial | 8 | 2005 | 393 | 0.440 |
Why?
|
Cost-Benefit Analysis | 8 | 2018 | 5462 | 0.440 |
Why?
|
Digestive System Surgical Procedures | 2 | 2018 | 568 | 0.430 |
Why?
|
United States | 37 | 2024 | 69573 | 0.430 |
Why?
|
Depression | 5 | 2024 | 7689 | 0.430 |
Why?
|
Vital Signs | 1 | 2013 | 141 | 0.420 |
Why?
|
Mental Status Schedule | 7 | 2001 | 321 | 0.420 |
Why?
|
Nursing Service, Hospital | 3 | 1999 | 17 | 0.420 |
Why?
|
Malnutrition | 1 | 2018 | 613 | 0.420 |
Why?
|
Analgesics, Opioid | 3 | 2022 | 3650 | 0.420 |
Why?
|
Haloperidol | 2 | 2023 | 397 | 0.410 |
Why?
|
Health Services Research | 8 | 2019 | 1832 | 0.400 |
Why?
|
Taiwan | 3 | 2018 | 493 | 0.400 |
Why?
|
Models, Theoretical | 3 | 2017 | 3609 | 0.400 |
Why?
|
Skull | 1 | 2016 | 809 | 0.390 |
Why?
|
Myxococcales | 6 | 1991 | 14 | 0.390 |
Why?
|
Mental Health | 4 | 2023 | 2946 | 0.390 |
Why?
|
Educational Status | 5 | 2008 | 2514 | 0.380 |
Why?
|
Cost of Illness | 6 | 2019 | 1849 | 0.380 |
Why?
|
C-Reactive Protein | 6 | 2021 | 3752 | 0.370 |
Why?
|
Algorithms | 12 | 2019 | 13872 | 0.370 |
Why?
|
Comorbidity | 13 | 2020 | 10362 | 0.370 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1428 | 0.370 |
Why?
|
Teaching Rounds | 2 | 2013 | 252 | 0.360 |
Why?
|
Disability Evaluation | 3 | 2016 | 1824 | 0.360 |
Why?
|
Pollen | 5 | 2001 | 75 | 0.360 |
Why?
|
Sensitivity and Specificity | 18 | 2022 | 14740 | 0.360 |
Why?
|
Leadership | 3 | 2017 | 1349 | 0.360 |
Why?
|
Cerebrovascular Circulation | 5 | 2016 | 2757 | 0.360 |
Why?
|
Postoperative Period | 3 | 2024 | 1835 | 0.350 |
Why?
|
Hip Fractures | 4 | 2018 | 953 | 0.350 |
Why?
|
Hospitals, University | 7 | 2008 | 567 | 0.340 |
Why?
|
Acetylcholine | 2 | 2008 | 622 | 0.340 |
Why?
|
Single-Blind Method | 4 | 2020 | 1585 | 0.330 |
Why?
|
Diffusion of Innovation | 4 | 2006 | 725 | 0.330 |
Why?
|
Quality Assurance, Health Care | 4 | 2011 | 2213 | 0.330 |
Why?
|
Risk Assessment | 15 | 2021 | 23294 | 0.330 |
Why?
|
Brain Diseases | 2 | 2010 | 1551 | 0.330 |
Why?
|
Patient-Centered Care | 2 | 2021 | 1435 | 0.330 |
Why?
|
Point-of-Care Systems | 2 | 2008 | 1175 | 0.330 |
Why?
|
Longitudinal Studies | 16 | 2023 | 13880 | 0.320 |
Why?
|
Patient Admission | 6 | 2020 | 1383 | 0.310 |
Why?
|
Patient Care Team | 6 | 2017 | 2527 | 0.310 |
Why?
|
Critical Illness | 6 | 2022 | 2656 | 0.310 |
Why?
|
Public Health | 2 | 2020 | 2587 | 0.310 |
Why?
|
Prognosis | 16 | 2021 | 28901 | 0.300 |
Why?
|
Selection Bias | 5 | 2022 | 370 | 0.300 |
Why?
|
Health Plan Implementation | 2 | 2021 | 351 | 0.300 |
Why?
|
Heart Diseases | 1 | 2020 | 2782 | 0.300 |
Why?
|
Motor Activity | 3 | 2014 | 2719 | 0.300 |
Why?
|
Electronic Health Records | 2 | 2022 | 4426 | 0.300 |
Why?
|
Health Care Costs | 4 | 2022 | 3226 | 0.290 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7726 | 0.290 |
Why?
|
Population Dynamics | 3 | 2019 | 300 | 0.290 |
Why?
|
Pandemics | 6 | 2023 | 8274 | 0.290 |
Why?
|
Health Policy | 2 | 2017 | 2655 | 0.290 |
Why?
|
Clinical Competence | 6 | 2018 | 4671 | 0.290 |
Why?
|
Physicians | 4 | 2018 | 4539 | 0.280 |
Why?
|
Decision Support Techniques | 2 | 2013 | 1957 | 0.280 |
Why?
|
Restraint, Physical | 4 | 2016 | 193 | 0.280 |
Why?
|
Wales | 3 | 2020 | 85 | 0.280 |
Why?
|
Hospital Administrators | 1 | 2006 | 57 | 0.280 |
Why?
|
Respiration, Artificial | 6 | 2022 | 2560 | 0.280 |
Why?
|
England | 4 | 2020 | 522 | 0.280 |
Why?
|
Age Factors | 14 | 2020 | 18349 | 0.270 |
Why?
|
Family | 4 | 2020 | 3141 | 0.270 |
Why?
|
Feasibility Studies | 7 | 2020 | 5058 | 0.260 |
Why?
|
Medicare | 6 | 2022 | 6497 | 0.260 |
Why?
|
Time Factors | 17 | 2020 | 40050 | 0.260 |
Why?
|
Hospital Mortality | 8 | 2023 | 5305 | 0.260 |
Why?
|
Massachusetts | 7 | 2020 | 8669 | 0.250 |
Why?
|
Publishing | 3 | 2021 | 828 | 0.250 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2006 | 1129 | 0.250 |
Why?
|
Follow-Up Studies | 13 | 2019 | 38942 | 0.240 |
Why?
|
Data Collection | 7 | 2015 | 3341 | 0.240 |
Why?
|
Polypharmacy | 3 | 2021 | 290 | 0.240 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2007 | 993 | 0.240 |
Why?
|
Emergency Service, Hospital | 7 | 2021 | 7626 | 0.240 |
Why?
|
Brain | 9 | 2019 | 26345 | 0.240 |
Why?
|
Costs and Cost Analysis | 2 | 2011 | 1675 | 0.240 |
Why?
|
Models, Nursing | 2 | 1993 | 44 | 0.240 |
Why?
|
Retroelements | 1 | 2005 | 163 | 0.230 |
Why?
|
Practice Guidelines as Topic | 5 | 2018 | 7274 | 0.230 |
Why?
|
Quality of Life | 8 | 2019 | 12640 | 0.230 |
Why?
|
Professional Role | 1 | 2006 | 305 | 0.230 |
Why?
|
Prevalence | 14 | 2021 | 15153 | 0.230 |
Why?
|
Rape | 1 | 2024 | 132 | 0.230 |
Why?
|
Cluster Analysis | 3 | 2020 | 2711 | 0.220 |
Why?
|
Monitoring, Intraoperative | 2 | 2020 | 954 | 0.220 |
Why?
|
Writing | 1 | 2005 | 205 | 0.220 |
Why?
|
Salaries and Fringe Benefits | 2 | 2022 | 264 | 0.220 |
Why?
|
Sex Factors | 6 | 2022 | 10398 | 0.220 |
Why?
|
Sleep | 1 | 2018 | 4596 | 0.220 |
Why?
|
Retrospective Studies | 15 | 2023 | 76631 | 0.220 |
Why?
|
Self Report | 3 | 2024 | 3524 | 0.210 |
Why?
|
Predictive Value of Tests | 16 | 2020 | 15036 | 0.210 |
Why?
|
Anesthesia, General | 3 | 2019 | 1164 | 0.210 |
Why?
|
Primary Health Care | 4 | 2015 | 4537 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.210 |
Why?
|
Financial Management | 2 | 2015 | 160 | 0.210 |
Why?
|
Chronic Disease | 3 | 2013 | 9133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.210 |
Why?
|
Boston | 5 | 2020 | 9314 | 0.210 |
Why?
|
Locomotion | 1 | 2004 | 379 | 0.210 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2022 | 1424 | 0.210 |
Why?
|
Health Status Indicators | 3 | 2012 | 969 | 0.210 |
Why?
|
Directive Counseling | 1 | 2003 | 166 | 0.200 |
Why?
|
Patient Satisfaction | 3 | 2015 | 3382 | 0.200 |
Why?
|
Diphenhydramine | 1 | 2001 | 63 | 0.200 |
Why?
|
Morbidity | 1 | 2007 | 1763 | 0.200 |
Why?
|
Hospital Costs | 4 | 2015 | 982 | 0.200 |
Why?
|
Treatment Outcome | 17 | 2020 | 62693 | 0.200 |
Why?
|
General Practice | 2 | 2020 | 99 | 0.200 |
Why?
|
Prejudice | 1 | 2005 | 572 | 0.200 |
Why?
|
Models, Organizational | 3 | 2016 | 573 | 0.200 |
Why?
|
Medical Order Entry Systems | 1 | 2007 | 544 | 0.200 |
Why?
|
Risperidone | 1 | 2023 | 383 | 0.190 |
Why?
|
Hospitalists | 2 | 2022 | 302 | 0.190 |
Why?
|
Risk | 8 | 2017 | 9684 | 0.190 |
Why?
|
Research Support as Topic | 1 | 2005 | 706 | 0.180 |
Why?
|
Hospitals, Teaching | 3 | 2003 | 1166 | 0.180 |
Why?
|
Proteomics | 4 | 2023 | 3584 | 0.180 |
Why?
|
Ketamine | 2 | 2017 | 498 | 0.180 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2019 | 108 | 0.180 |
Why?
|
Genome, Bacterial | 1 | 2005 | 756 | 0.180 |
Why?
|
Episode of Care | 1 | 2020 | 125 | 0.180 |
Why?
|
Observer Variation | 4 | 2018 | 2589 | 0.170 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2002 | 392 | 0.170 |
Why?
|
Plant Proteins | 3 | 2000 | 361 | 0.170 |
Why?
|
Blood-Brain Barrier | 2 | 2021 | 1015 | 0.170 |
Why?
|
Queensland | 1 | 2018 | 41 | 0.170 |
Why?
|
Pneumonia | 4 | 2022 | 2102 | 0.170 |
Why?
|
Health Personnel | 3 | 2019 | 3203 | 0.170 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 1998 | 27 | 0.170 |
Why?
|
Organ Size | 3 | 2016 | 2247 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 9812 | 0.170 |
Why?
|
Evoked Potentials, Auditory | 1 | 2022 | 525 | 0.170 |
Why?
|
Australia | 1 | 2022 | 1162 | 0.160 |
Why?
|
Multivariate Analysis | 11 | 2017 | 12237 | 0.160 |
Why?
|
Cross-Sectional Studies | 14 | 2016 | 24714 | 0.160 |
Why?
|
Neurofilament Proteins | 1 | 2020 | 316 | 0.160 |
Why?
|
Motivation | 1 | 2008 | 1965 | 0.160 |
Why?
|
Organizational Case Studies | 2 | 2011 | 299 | 0.160 |
Why?
|
Myxococcus xanthus | 3 | 1992 | 13 | 0.160 |
Why?
|
tau Proteins | 4 | 2024 | 1861 | 0.160 |
Why?
|
Abortion, Induced | 1 | 2024 | 441 | 0.160 |
Why?
|
Preventive Medicine | 1 | 2020 | 263 | 0.160 |
Why?
|
Odds Ratio | 5 | 2015 | 9846 | 0.160 |
Why?
|
Models, Statistical | 4 | 2010 | 5113 | 0.160 |
Why?
|
Coronary Artery Bypass | 3 | 2020 | 2272 | 0.160 |
Why?
|
Linear Models | 7 | 2017 | 5948 | 0.160 |
Why?
|
Cytokines | 3 | 2019 | 7298 | 0.160 |
Why?
|
Matched-Pair Analysis | 1 | 1998 | 289 | 0.160 |
Why?
|
Case-Control Studies | 11 | 2023 | 21694 | 0.150 |
Why?
|
Psychotropic Drugs | 1 | 2023 | 891 | 0.150 |
Why?
|
Health Status | 4 | 2019 | 4013 | 0.150 |
Why?
|
Career Choice | 1 | 2024 | 742 | 0.150 |
Why?
|
Middle Aged | 33 | 2022 | 212863 | 0.150 |
Why?
|
Regression Analysis | 6 | 2016 | 6452 | 0.150 |
Why?
|
Anesthesia | 2 | 2019 | 1543 | 0.150 |
Why?
|
Epistasis, Genetic | 1 | 2020 | 365 | 0.150 |
Why?
|
Proteome | 3 | 2022 | 1772 | 0.150 |
Why?
|
Anesthetics, General | 1 | 2019 | 152 | 0.150 |
Why?
|
Cognitive Reserve | 1 | 2017 | 75 | 0.150 |
Why?
|
Cooperative Behavior | 2 | 2017 | 1503 | 0.150 |
Why?
|
Hospital Volunteers | 1 | 2016 | 6 | 0.150 |
Why?
|
Guideline Adherence | 2 | 2006 | 2261 | 0.150 |
Why?
|
Central Nervous System Agents | 1 | 2017 | 71 | 0.140 |
Why?
|
Cost Savings | 2 | 2013 | 925 | 0.140 |
Why?
|
Nucleic Acid Conformation | 7 | 2005 | 913 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 306 | 0.140 |
Why?
|
Informed Consent | 3 | 2017 | 988 | 0.140 |
Why?
|
Catechol O-Methyltransferase | 1 | 2018 | 245 | 0.140 |
Why?
|
Escherichia coli | 8 | 2000 | 4220 | 0.140 |
Why?
|
Precipitating Factors | 1 | 1996 | 53 | 0.140 |
Why?
|
Research | 3 | 2016 | 2001 | 0.140 |
Why?
|
Allergens | 5 | 2001 | 1308 | 0.140 |
Why?
|
Cerebral Cortex | 3 | 2020 | 5721 | 0.140 |
Why?
|
Medication Errors | 2 | 2015 | 797 | 0.130 |
Why?
|
Survival Rate | 5 | 2020 | 12761 | 0.130 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1998 | 618 | 0.130 |
Why?
|
Physician Assistants | 1 | 2018 | 194 | 0.130 |
Why?
|
Macaca | 4 | 2001 | 443 | 0.130 |
Why?
|
Apolipoprotein E4 | 2 | 2020 | 669 | 0.130 |
Why?
|
Probability | 2 | 2003 | 2500 | 0.130 |
Why?
|
Neuronal Plasticity | 2 | 2017 | 1416 | 0.130 |
Why?
|
Forecasting | 4 | 2008 | 2952 | 0.130 |
Why?
|
Apolipoprotein E2 | 1 | 2015 | 127 | 0.130 |
Why?
|
Review Literature as Topic | 1 | 2017 | 328 | 0.120 |
Why?
|
Pilot Projects | 5 | 2022 | 8275 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 10 | 2022 | 35326 | 0.120 |
Why?
|
Academic Medical Centers | 5 | 2012 | 2749 | 0.120 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12948 | 0.120 |
Why?
|
Cause of Death | 2 | 2020 | 3564 | 0.120 |
Why?
|
Motor Cortex | 1 | 2022 | 984 | 0.120 |
Why?
|
Genes, Bacterial | 4 | 1991 | 1078 | 0.120 |
Why?
|
Anesthetics, Dissociative | 1 | 2014 | 80 | 0.120 |
Why?
|
Information Dissemination | 3 | 2015 | 1106 | 0.120 |
Why?
|
Apolipoproteins E | 1 | 2020 | 1437 | 0.120 |
Why?
|
Proportional Hazards Models | 7 | 2009 | 12328 | 0.120 |
Why?
|
China | 1 | 2020 | 2225 | 0.120 |
Why?
|
Cerebral Arteries | 1 | 2016 | 492 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2001 | 740 | 0.120 |
Why?
|
Hearing Loss | 1 | 2021 | 759 | 0.120 |
Why?
|
Stress, Psychological | 3 | 2007 | 4212 | 0.120 |
Why?
|
Research Personnel | 1 | 2018 | 571 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 968 | 0.120 |
Why?
|
Anticonvulsants | 1 | 2023 | 1907 | 0.120 |
Why?
|
Glycoproteins | 2 | 1991 | 2259 | 0.110 |
Why?
|
Molecular Sequence Data | 15 | 2000 | 18125 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2008 | 3514 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2019 | 1008 | 0.110 |
Why?
|
Inappropriate Prescribing | 1 | 2015 | 199 | 0.110 |
Why?
|
Canada | 3 | 2019 | 2021 | 0.110 |
Why?
|
Income | 1 | 2022 | 1877 | 0.110 |
Why?
|
Decision Making, Organizational | 2 | 2011 | 139 | 0.110 |
Why?
|
Base Sequence | 13 | 1998 | 12804 | 0.110 |
Why?
|
Amyloid beta-Peptides | 3 | 2024 | 3579 | 0.110 |
Why?
|
Reference Standards | 4 | 2020 | 1018 | 0.110 |
Why?
|
Certification | 1 | 2016 | 424 | 0.110 |
Why?
|
Decision Making | 2 | 2017 | 3854 | 0.110 |
Why?
|
Hospital Information Systems | 1 | 2015 | 395 | 0.110 |
Why?
|
Computational Biology | 2 | 2022 | 3506 | 0.110 |
Why?
|
Patient Compliance | 1 | 2003 | 2679 | 0.110 |
Why?
|
Qualitative Research | 5 | 2021 | 2656 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1409 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20055 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 2016 | 1437 | 0.110 |
Why?
|
Attention | 3 | 2020 | 2400 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3510 | 0.100 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1339 | 0.100 |
Why?
|
Total Quality Management | 2 | 2006 | 274 | 0.100 |
Why?
|
Hospital Bed Capacity, 500 and over | 3 | 1998 | 115 | 0.100 |
Why?
|
Coliphages | 1 | 1991 | 120 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2836 | 0.100 |
Why?
|
Calibration | 1 | 2014 | 818 | 0.100 |
Why?
|
Syndrome | 3 | 2019 | 3241 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2014 | 677 | 0.100 |
Why?
|
Politics | 1 | 2017 | 782 | 0.100 |
Why?
|
State Medicine | 3 | 2019 | 219 | 0.100 |
Why?
|
Cerebral Angiography | 1 | 2016 | 1282 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 1993 | 306 | 0.090 |
Why?
|
Executive Function | 1 | 2019 | 1356 | 0.090 |
Why?
|
Primary Prevention | 1 | 1998 | 1165 | 0.090 |
Why?
|
Automobile Driving | 1 | 2015 | 431 | 0.090 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1904 | 0.090 |
Why?
|
Logistic Models | 8 | 2020 | 13402 | 0.090 |
Why?
|
Interdisciplinary Communication | 2 | 2017 | 952 | 0.090 |
Why?
|
Genes, Viral | 1 | 1991 | 719 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 2881 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2021 | 5076 | 0.090 |
Why?
|
Education, Continuing | 1 | 2010 | 112 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1441 | 0.090 |
Why?
|
Confidence Intervals | 3 | 2003 | 2974 | 0.090 |
Why?
|
Gait | 1 | 2015 | 781 | 0.090 |
Why?
|
Monkey Diseases | 2 | 1999 | 77 | 0.090 |
Why?
|
Delphi Technique | 1 | 2012 | 770 | 0.090 |
Why?
|
Nurses | 1 | 2019 | 2455 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2003 | 7897 | 0.090 |
Why?
|
Clinical Medicine | 1 | 2010 | 148 | 0.080 |
Why?
|
Factor Analysis, Statistical | 3 | 2013 | 976 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2005 | 6370 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1991 | 1721 | 0.080 |
Why?
|
Lewy Body Disease | 1 | 2011 | 223 | 0.080 |
Why?
|
APACHE | 3 | 2004 | 277 | 0.080 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 1999 | 98 | 0.080 |
Why?
|
Organizational Innovation | 2 | 2004 | 559 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1637 | 0.080 |
Why?
|
Parents | 1 | 2022 | 3368 | 0.080 |
Why?
|
Atrophy | 3 | 2020 | 1571 | 0.080 |
Why?
|
RNA, Transfer | 1 | 1991 | 315 | 0.080 |
Why?
|
Psychomotor Disorders | 1 | 2009 | 152 | 0.080 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 256 | 0.080 |
Why?
|
Blotting, Southern | 4 | 1992 | 803 | 0.080 |
Why?
|
Protein Kinases | 2 | 1992 | 1637 | 0.080 |
Why?
|
Nutrition Disorders | 2 | 2000 | 210 | 0.080 |
Why?
|
Receptors, Neurotransmitter | 1 | 2008 | 178 | 0.080 |
Why?
|
Urinary Catheterization | 2 | 2000 | 200 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2015 | 1548 | 0.080 |
Why?
|
Education | 3 | 2013 | 543 | 0.080 |
Why?
|
Causality | 3 | 2007 | 1262 | 0.080 |
Why?
|
Urinary Incontinence | 2 | 2007 | 490 | 0.080 |
Why?
|
Evaluation Studies as Topic | 2 | 2019 | 1676 | 0.080 |
Why?
|
Nursing Education Research | 1 | 2007 | 12 | 0.080 |
Why?
|
Phlebotomy | 1 | 2008 | 142 | 0.080 |
Why?
|
Diagnosis-Related Groups | 1 | 2009 | 453 | 0.080 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2012 | 717 | 0.080 |
Why?
|
Psychiatric Nursing | 1 | 2007 | 17 | 0.080 |
Why?
|
Vision Disorders | 3 | 2001 | 1058 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3863 | 0.070 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2006 | 71 | 0.070 |
Why?
|
Endoribonucleases | 1 | 1989 | 228 | 0.070 |
Why?
|
Inflammation | 3 | 2022 | 10534 | 0.070 |
Why?
|
Disease Progression | 5 | 2019 | 13237 | 0.070 |
Why?
|
Syncope | 1 | 2010 | 431 | 0.070 |
Why?
|
Tomography, X-Ray | 1 | 1986 | 60 | 0.070 |
Why?
|
Southeastern United States | 1 | 2007 | 94 | 0.070 |
Why?
|
Home Care Services | 1 | 1993 | 602 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1638 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2301 | 0.070 |
Why?
|
Netherlands | 3 | 2017 | 2169 | 0.070 |
Why?
|
Leptospirosis | 1 | 2006 | 30 | 0.070 |
Why?
|
RNA Precursors | 1 | 1987 | 207 | 0.070 |
Why?
|
Remote Consultation | 1 | 2009 | 239 | 0.070 |
Why?
|
Geriatric Psychiatry | 1 | 2007 | 70 | 0.070 |
Why?
|
Leisure Activities | 1 | 2008 | 311 | 0.070 |
Why?
|
Spinal Puncture | 1 | 2008 | 284 | 0.070 |
Why?
|
Trazodone | 1 | 2006 | 66 | 0.070 |
Why?
|
Lymphocytosis | 1 | 2006 | 118 | 0.070 |
Why?
|
Cholinergic Antagonists | 1 | 2006 | 162 | 0.070 |
Why?
|
Protein Precursors | 2 | 1983 | 1154 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2007 | 154 | 0.070 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2005 | 44 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2006 | 3497 | 0.070 |
Why?
|
ROC Curve | 1 | 2013 | 3526 | 0.070 |
Why?
|
Dehydration | 2 | 2000 | 230 | 0.070 |
Why?
|
Japan | 5 | 2001 | 1348 | 0.070 |
Why?
|
Drug Utilization Review | 1 | 2007 | 245 | 0.070 |
Why?
|
Neoplasms | 4 | 2016 | 21507 | 0.070 |
Why?
|
Gene Expression | 3 | 2002 | 7788 | 0.070 |
Why?
|
Knowledge | 1 | 2007 | 174 | 0.070 |
Why?
|
Lorazepam | 1 | 2006 | 146 | 0.070 |
Why?
|
Image Enhancement | 1 | 2016 | 2928 | 0.060 |
Why?
|
Amino Acid Sequence | 9 | 1998 | 13816 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2275 | 0.060 |
Why?
|
Computer Systems | 1 | 2007 | 484 | 0.060 |
Why?
|
Lipoproteins | 2 | 1983 | 880 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 4 | 1998 | 1088 | 0.060 |
Why?
|
Adult | 16 | 2022 | 213394 | 0.060 |
Why?
|
DNA Transposable Elements | 2 | 2005 | 749 | 0.060 |
Why?
|
Thoracic Neoplasms | 1 | 1986 | 267 | 0.060 |
Why?
|
Neurotransmitter Agents | 1 | 2008 | 646 | 0.060 |
Why?
|
Bed Rest | 1 | 2004 | 84 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3180 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3575 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2732 | 0.060 |
Why?
|
Registries | 2 | 2010 | 8039 | 0.060 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 69 | 0.060 |
Why?
|
Isoflurane | 1 | 2006 | 381 | 0.060 |
Why?
|
Anti-Anxiety Agents | 1 | 2006 | 390 | 0.060 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 670 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2006 | 1528 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2904 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 794 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6516 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3279 | 0.050 |
Why?
|
Abortion, Legal | 1 | 2024 | 112 | 0.050 |
Why?
|
Michigan | 1 | 2023 | 349 | 0.050 |
Why?
|
Physical Examination | 2 | 2006 | 1231 | 0.050 |
Why?
|
Coma | 2 | 2022 | 471 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4035 | 0.050 |
Why?
|
Nursing Evaluation Research | 1 | 2001 | 26 | 0.050 |
Why?
|
Nursing Diagnosis | 1 | 2021 | 18 | 0.050 |
Why?
|
Proxy | 1 | 2003 | 144 | 0.050 |
Why?
|
Ambulatory Care Facilities | 2 | 1998 | 928 | 0.050 |
Why?
|
Serotonin | 1 | 2006 | 1022 | 0.050 |
Why?
|
Immunoglobulin E | 4 | 2001 | 1461 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1162 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 11699 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2012 | 1515 | 0.050 |
Why?
|
Belgium | 1 | 2021 | 103 | 0.050 |
Why?
|
Parietal Lobe | 1 | 2006 | 834 | 0.050 |
Why?
|
Consensus | 3 | 2017 | 2913 | 0.050 |
Why?
|
Psychiatry | 1 | 2014 | 1686 | 0.050 |
Why?
|
Anesthetics, Inhalation | 1 | 2006 | 571 | 0.050 |
Why?
|
Social Behavior | 1 | 2008 | 1131 | 0.050 |
Why?
|
Drug Utilization | 1 | 2008 | 1181 | 0.050 |
Why?
|
Hypersensitivity | 2 | 2001 | 1086 | 0.050 |
Why?
|
Pituitary Gland, Anterior | 2 | 1991 | 177 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 780 | 0.050 |
Why?
|
Health Surveys | 2 | 2008 | 4022 | 0.050 |
Why?
|
Oligonucleotide Probes | 2 | 1991 | 425 | 0.050 |
Why?
|
Job Description | 1 | 2000 | 59 | 0.050 |
Why?
|
Melatonin | 1 | 2006 | 719 | 0.050 |
Why?
|
Perception | 1 | 2007 | 1177 | 0.050 |
Why?
|
Inhibins | 2 | 1991 | 212 | 0.050 |
Why?
|
Aequorin | 1 | 2000 | 15 | 0.050 |
Why?
|
Models, Econometric | 1 | 2001 | 221 | 0.050 |
Why?
|
Follistatin | 2 | 1991 | 141 | 0.050 |
Why?
|
Amino Acids | 1 | 2006 | 1727 | 0.050 |
Why?
|
Artemisia | 1 | 1999 | 1 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2023 | 572 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2008 | 2448 | 0.050 |
Why?
|
Drug Evaluation | 1 | 2021 | 637 | 0.050 |
Why?
|
Poaceae | 1 | 1999 | 25 | 0.050 |
Why?
|
Genetic Markers | 1 | 2006 | 2630 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2006 | 1409 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1983 | 406 | 0.040 |
Why?
|
Rehabilitation | 1 | 2021 | 134 | 0.040 |
Why?
|
Dementia, Vascular | 1 | 2001 | 127 | 0.040 |
Why?
|
Bacteria | 1 | 1991 | 2106 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2023 | 327 | 0.040 |
Why?
|
Survival Analysis | 3 | 2004 | 10247 | 0.040 |
Why?
|
Tennessee | 1 | 2019 | 117 | 0.040 |
Why?
|
Hearing | 2 | 2021 | 478 | 0.040 |
Why?
|
Managed Care Programs | 1 | 2005 | 949 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2010 | 2146 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 183 | 0.040 |
Why?
|
History, 21st Century | 1 | 2015 | 1534 | 0.040 |
Why?
|
Plants, Medicinal | 1 | 1999 | 167 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 526 | 0.040 |
Why?
|
Chromosomes, Bacterial | 2 | 1992 | 283 | 0.040 |
Why?
|
Terminally Ill | 1 | 2001 | 238 | 0.040 |
Why?
|
Demography | 1 | 2024 | 1650 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2022 | 455 | 0.040 |
Why?
|
Plasma | 1 | 2022 | 573 | 0.040 |
Why?
|
New York City | 1 | 2001 | 704 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2583 | 0.040 |
Why?
|
Caffeine | 1 | 2023 | 697 | 0.040 |
Why?
|
Immunization Programs | 1 | 2001 | 267 | 0.040 |
Why?
|
Marital Status | 1 | 2000 | 435 | 0.040 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2019 | 118 | 0.040 |
Why?
|
Social Values | 1 | 1999 | 225 | 0.040 |
Why?
|
Phenylephrine | 1 | 2019 | 302 | 0.040 |
Why?
|
Mental Competency | 1 | 2019 | 175 | 0.040 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 194 | 0.040 |
Why?
|
Cysteine | 1 | 1983 | 870 | 0.040 |
Why?
|
Case Management | 1 | 2000 | 287 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 546 | 0.040 |
Why?
|
Blotting, Western | 3 | 2006 | 5181 | 0.040 |
Why?
|
Pennsylvania | 1 | 2019 | 615 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
Social Support | 2 | 2001 | 2112 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 190 | 0.040 |
Why?
|
Procollagen | 1 | 1998 | 185 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2020 | 6361 | 0.040 |
Why?
|
Cricetinae | 2 | 1991 | 2468 | 0.040 |
Why?
|
Research Subjects | 1 | 2019 | 237 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 1983 | 1070 | 0.040 |
Why?
|
History, 20th Century | 1 | 2015 | 2742 | 0.040 |
Why?
|
Focus Groups | 2 | 2013 | 1308 | 0.040 |
Why?
|
Cell-Free System | 3 | 1994 | 346 | 0.040 |
Why?
|
Blood Proteins | 1 | 2022 | 1122 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1998 | 2049 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17384 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2013 | 3908 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2006 | 2687 | 0.040 |
Why?
|
Genetic Variation | 1 | 1992 | 6539 | 0.040 |
Why?
|
Alleles | 2 | 2020 | 6942 | 0.030 |
Why?
|
Antibody Formation | 1 | 2001 | 1398 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2007 | 2674 | 0.030 |
Why?
|
Recombinant Proteins | 4 | 2000 | 6610 | 0.030 |
Why?
|
Safety | 1 | 2001 | 1186 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 1983 | 1054 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2019 | 535 | 0.030 |
Why?
|
Species Specificity | 1 | 2000 | 2480 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 1999 | 481 | 0.030 |
Why?
|
Echovirus Infections | 1 | 1994 | 7 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3844 | 0.030 |
Why?
|
Awards and Prizes | 1 | 2019 | 375 | 0.030 |
Why?
|
Spin Labels | 1 | 2016 | 334 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2001 | 1603 | 0.030 |
Why?
|
Eligibility Determination | 1 | 2018 | 403 | 0.030 |
Why?
|
Enterovirus B, Human | 1 | 1994 | 52 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3021 | 0.030 |
Why?
|
Medical Oncology | 2 | 2016 | 2217 | 0.030 |
Why?
|
Psychomotor Performance | 2 | 2020 | 1899 | 0.030 |
Why?
|
Meningitis, Aseptic | 1 | 1994 | 59 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2001 | 1407 | 0.030 |
Why?
|
Imidazoles | 1 | 2000 | 1207 | 0.030 |
Why?
|
Risk-Taking | 1 | 1999 | 986 | 0.030 |
Why?
|
Video Recording | 1 | 2018 | 936 | 0.030 |
Why?
|
Education, Nursing, Continuing | 1 | 1993 | 75 | 0.030 |
Why?
|
Survivors | 1 | 2024 | 2280 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2200 | 0.030 |
Why?
|
Patients | 1 | 2000 | 890 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2017 | 766 | 0.030 |
Why?
|
Transfection | 2 | 1991 | 5884 | 0.030 |
Why?
|
Membrane Proteins | 2 | 1983 | 7862 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
Genotype | 2 | 2020 | 12951 | 0.030 |
Why?
|
Hypotension | 1 | 2019 | 881 | 0.030 |
Why?
|
Technology, Radiologic | 1 | 1993 | 163 | 0.030 |
Why?
|
Palliative Care | 1 | 2007 | 3461 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 1999 | 1778 | 0.030 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2012 | 65 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1460 | 0.030 |
Why?
|
Animals | 12 | 2023 | 168368 | 0.030 |
Why?
|
Cattle | 1 | 1998 | 3913 | 0.030 |
Why?
|
Molecular Weight | 2 | 1989 | 2257 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3194 | 0.030 |
Why?
|
Sample Size | 1 | 2015 | 845 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2017 | 11985 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 2 | 1991 | 1372 | 0.030 |
Why?
|
Health Planning | 1 | 1993 | 237 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1184 | 0.030 |
Why?
|
Longevity | 1 | 2019 | 1066 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 1992 | 294 | 0.030 |
Why?
|
Exercise | 1 | 2008 | 5591 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2013 | 213 | 0.030 |
Why?
|
Attitude to Health | 1 | 2001 | 2047 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2016 | 760 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3263 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1469 | 0.020 |
Why?
|
Open Reading Frames | 2 | 1991 | 810 | 0.020 |
Why?
|
Models, Neurological | 1 | 1999 | 1769 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1992 | 769 | 0.020 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2011 | 141 | 0.020 |
Why?
|
Homeostasis | 1 | 2002 | 3348 | 0.020 |
Why?
|
Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
Individuality | 1 | 2012 | 303 | 0.020 |
Why?
|
Likelihood Functions | 1 | 1993 | 1004 | 0.020 |
Why?
|
Apoptosis | 1 | 2006 | 9714 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1991 | 550 | 0.020 |
Why?
|
Activins | 1 | 1991 | 208 | 0.020 |
Why?
|
Nucleotide Mapping | 1 | 1989 | 20 | 0.020 |
Why?
|
Mental Disorders | 1 | 2010 | 6570 | 0.020 |
Why?
|
Influenza, Human | 1 | 2001 | 1476 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3232 | 0.020 |
Why?
|
Verbal Learning | 1 | 2012 | 466 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1993 | 932 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1989 | 314 | 0.020 |
Why?
|
Cricetulus | 1 | 1991 | 814 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2011 | 339 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2011 | 239 | 0.020 |
Why?
|
Terminal Care | 1 | 2001 | 1688 | 0.020 |
Why?
|
Ribonuclease H | 1 | 1989 | 44 | 0.020 |
Why?
|
Anesthesiology | 1 | 2019 | 1043 | 0.020 |
Why?
|
Antigens, Plant | 2 | 1999 | 86 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1992 | 4319 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8605 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1991 | 739 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4935 | 0.020 |
Why?
|
Ovariectomy | 1 | 1991 | 660 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2006 | 10142 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1989 | 672 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1735 | 0.020 |
Why?
|
Nutritional Status | 1 | 2017 | 1587 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2008 | 147 | 0.020 |
Why?
|
Glycosylation | 1 | 1991 | 1125 | 0.020 |
Why?
|
Cell Division | 3 | 2001 | 4575 | 0.020 |
Why?
|
Templates, Genetic | 1 | 1987 | 211 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1991 | 2665 | 0.020 |
Why?
|
Family Practice | 1 | 2010 | 516 | 0.020 |
Why?
|
Hospitals, Veterans | 1 | 2010 | 404 | 0.020 |
Why?
|
Mephitidae | 1 | 2006 | 1 | 0.020 |
Why?
|
Raccoons | 1 | 2006 | 8 | 0.020 |
Why?
|
Education, Medical | 1 | 1999 | 1712 | 0.020 |
Why?
|
Codon | 1 | 1989 | 613 | 0.020 |
Why?
|
Cell Line | 2 | 1991 | 15987 | 0.020 |
Why?
|
Ovary | 1 | 1991 | 982 | 0.020 |
Why?
|
RNA Splicing | 1 | 1991 | 904 | 0.020 |
Why?
|
Economics, Hospital | 1 | 2009 | 213 | 0.020 |
Why?
|
Biological Evolution | 1 | 1992 | 1072 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 1999 | 3217 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1992 | 6174 | 0.020 |
Why?
|
Communication | 1 | 1999 | 3722 | 0.020 |
Why?
|
Interdepartmental Relations | 1 | 2004 | 13 | 0.020 |
Why?
|
Rats | 2 | 1991 | 24270 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1994 | 1779 | 0.020 |
Why?
|
Lung Diseases, Obstructive | 1 | 2005 | 316 | 0.020 |
Why?
|
Mental Recall | 1 | 2011 | 1201 | 0.020 |
Why?
|
Phylogeny | 1 | 1992 | 2789 | 0.020 |
Why?
|
DNA, Viral | 1 | 1991 | 2223 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 56255 | 0.010 |
Why?
|
Cellulitis | 1 | 2005 | 206 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2711 | 0.010 |
Why?
|
New England | 1 | 2006 | 1021 | 0.010 |
Why?
|
Mediastinal Neoplasms | 1 | 1986 | 421 | 0.010 |
Why?
|
Educational Measurement | 1 | 2010 | 1205 | 0.010 |
Why?
|
Memory | 1 | 1993 | 2161 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1977 | 3866 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2006 | 19220 | 0.010 |
Why?
|
Protein Binding | 2 | 2000 | 9375 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1991 | 4743 | 0.010 |
Why?
|
Hippocampus | 1 | 2015 | 3657 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 2 | 1999 | 1820 | 0.010 |
Why?
|
Parkinson Disease | 1 | 2016 | 2780 | 0.010 |
Why?
|
Seasons | 2 | 2001 | 1486 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29002 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 2005 | 463 | 0.010 |
Why?
|
Adolescent | 3 | 2022 | 85405 | 0.010 |
Why?
|
Cedrus | 1 | 2001 | 2 | 0.010 |
Why?
|
Dogs | 1 | 2006 | 3915 | 0.010 |
Why?
|
Phenotype | 2 | 2016 | 16301 | 0.010 |
Why?
|
Swine | 1 | 1991 | 5901 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1992 | 2748 | 0.010 |
Why?
|
Neuroglia | 1 | 2006 | 928 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1121 | 0.010 |
Why?
|
Scyphozoa | 1 | 2000 | 11 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 708 | 0.010 |
Why?
|
Trees | 1 | 1999 | 58 | 0.010 |
Why?
|
Mutation | 2 | 2002 | 29658 | 0.010 |
Why?
|
Mutagenesis | 1 | 1983 | 1265 | 0.010 |
Why?
|
DNA | 1 | 1992 | 7275 | 0.010 |
Why?
|
Toluene | 1 | 1977 | 32 | 0.010 |
Why?
|
Models, Genetic | 1 | 1987 | 3493 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7690 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2000 | 1245 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1991 | 13002 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2001 | 744 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2000 | 2015 | 0.010 |
Why?
|
Child | 2 | 2001 | 77033 | 0.010 |
Why?
|
Urban Population | 1 | 2003 | 2014 | 0.010 |
Why?
|
RNA, Transfer, Lys | 1 | 1994 | 10 | 0.010 |
Why?
|
Pyrazines | 1 | 2000 | 1232 | 0.010 |
Why?
|
Binding Sites | 1 | 1983 | 6113 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8977 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1987 | 7709 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2833 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1995 | 370 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 1 | 1994 | 215 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3311 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 1991 | 104 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 4012 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1992 | 475 | 0.010 |
Why?
|
Vision, Ocular | 1 | 1995 | 471 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2007 | 3401 | 0.010 |
Why?
|
Spores, Bacterial | 1 | 1991 | 119 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 879 | 0.010 |
Why?
|
DNA, Fungal | 1 | 1992 | 277 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1991 | 572 | 0.010 |
Why?
|
Physical Fitness | 1 | 1995 | 733 | 0.010 |
Why?
|
Smoking | 1 | 2007 | 8960 | 0.010 |
Why?
|
Models, Psychological | 1 | 1994 | 809 | 0.010 |
Why?
|
Models, Molecular | 1 | 2000 | 5460 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1994 | 1798 | 0.010 |
Why?
|
DNA Primers | 1 | 1994 | 2893 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2001 | 4522 | 0.010 |
Why?
|
Cell Membrane | 1 | 1977 | 3747 | 0.000 |
Why?
|
Plasmids | 1 | 1992 | 2307 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1991 | 1402 | 0.000 |
Why?
|
Calcium | 1 | 2000 | 5742 | 0.000 |
Why?
|
Gene Rearrangement | 1 | 1992 | 1178 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2007 | 11668 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2001 | 4815 | 0.000 |
Why?
|
Phosphoproteins | 1 | 1991 | 2440 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1986 | 12985 | 0.000 |
Why?
|
Anxiety | 1 | 1995 | 4253 | 0.000 |
Why?
|
Drosophila melanogaster | 1 | 1986 | 1703 | 0.000 |
Why?
|
HIV-1 | 1 | 1994 | 6931 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 25470 | 0.000 |
Why?
|
Infant | 1 | 1994 | 34923 | 0.000 |
Why?
|
Child, Preschool | 1 | 1994 | 40802 | 0.000 |
Why?
|